Digital technologies in self-monitoring of blood glucose and their clinical significance
https://doi.org/10.21518/ms2025-168
Abstract
In the 21st century, the prevalence of diabetes mellitus (DM) has increased significantly both in the Russian Federation and worldwide. Objective: to characterize the methods for diagnosing DM, analyze the clinical significance of self-monitoring of blood glucose (SMBG), and the impact of digital SBG technologies on glycemic control in DM patients and their adherence to DM treatment. Many international (UKPDS, DCCT, ACCORD, ADVANCE, VADT) and Russian (Federal Register of DM in the Russian Federation) studies have shown that DM not only leads to a number of complications, but also increases the risk of cardiovascular diseases, which are the main cause of death in patients with DM. Hyperglycemia determines DM, and glycemic control is fundamental for DM treatment. To minimize the risk of DM complications, patients need to maintain glycemia within target values using various methods (HbA1c determination, continuous glucose monitoring, flash glucose monitoring etc.), as well as with the help of structured SMBG. The modern high-precision glucometer Contour®Plus ONE with the Russianlanguage mobile application ContourTMDiabetes is simple and easy to use, equipped with additional options, as well as a function for remote monitoring of the glucose level, which improves the clinical and economic effectiveness of T2DM treatment and can help limit the progression of the disease. In conclusion, in the era of precision medicine, the use of digital health technologies in SMBG provides a strategy for increasing adherence to treatment in patients with DM, and therefore the effectiveness and safety of DM treatment in real conditions.
Keywords
diabetes mellitus,
diagnostic methods,
self-monitoring of blood glucose,
glucometer,
mobile application
Supporting agencies: The work was carried out within the framework of the topic of the state task “Study of molecular genetic and molecular biological mechanisms of the development of common therapeutic diseases in Siberia to improve approaches to their early diagnosis and prevention”, 2024–2028 (FWNR-2024-0004).
About the Authors
I. N. Grigor’eva
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Irina N. Grigor’eva, Dr. Sci. (Med.), Professor, chief Researcher, Professor of the Education Department
175/1, Boris Bogatkov St., Novosibirsk, 630089, Russia
N. L. Tov
Novosibirsk State Medical University
Russian Federation
Russian Federation
Nikita L. Tov, Dr. Sci. (Med.), Professor, Head of the Department of Internal Medicine named after Academician L.D. Sidorova, Faculty of Medicine
52, Krasny Ave., Novosibirsk, 630091, Russia
References
1. Resolution on Diabetes Mellitus from United Nations organization. Diabetes Mellitus. 2007;10(1):2–3. (In Russ.) https://doi.org/10.14341/2072-0351-5906.
2. M Magliano DJ, Boyko EJ. IDF DIABETES ATLAS. 10th ed. Brussels: International Diabetes Federation; 2021. Available at: https://pubmed.ncbi.nlm.nih.gov/35914061.
3. Oser SM, Stuckey HL, Parascando JA, McGinley EL, Berg A, Oser TK. Glycated Hemoglobin Differences Among Blog-Reading Adults With Type 1 Diabetes Compared With Those Who Do Not Read Blogs: Cross-Sectional Study. JMIR Diabetes. 2019;4(2):e13634. https://doi.org/10.2196/13634.
4. Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Sazonova DV et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes Mellitus. 2023;26(2):104–123. (In Russ.) https://doi.org/10.14341/DM13035.
5. Kuzina IA, Goncharova EV, Martirosian NS, Telnova ME, Nedosugova LV, Tulsky AA et al. Historical aspects of diagnosis and control of diabetes mellitus. Terapevticheskii Arkhiv. 2022;94(10):1216–1220. (In Russ.) https://doi.org/10.26442/00403660.2022.10.201890.
6. Suplotova LA, Alieva OO. Evolution of blood glucose self-monitoring technology. Diabetes Mellitus. 2023;26(6):566–574. (In Russ.) https://doi.org/10.14341/DM13063
7. Dedov II, Shestakova MV, Mayorov AYu, Mokrysheva NG, Vikulova OK, Galstyan GR et al. Standards of specialized diabetes care. Diabetes Mellitus. 2021;24(1 Suppl.):1–148. (In Russ.) https://doi.org/10.14341/DM12802.
8. American Diabetes Association 6. Glycemic targets. Diabetes Care. 2015;38(Suppl. 1):S33-S40. https://doi.org/10.2337/dc15-S009.
9. Mannucci E, Antenore A, Giorgino F, Scavini M. Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Sci Technol. 2018;12(1):183–189. https://doi.org/10.1177/1932296817719290.
10. Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB et al.; T1D Exchange Clinic Network. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013;36(7):2009–2014. https://doi.org/10.2337/dc12-1770.
11. Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M et al. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. https://doi.org/10.1056/NEJM199309303291401.
12. Kimura M, Toyoda M, Saito N, Takahashi M, Isozumi K, Kato E et al. The Importance of Patient and Family Engagement, the Needs for SelfMonitoring of Blood Glucose (SMBG) – Our Perspectives Learned Through a Story of SMBG Assistive Devices Made by a Husband of the Patient with Diabetes. Diabetes Metab Syndr Obes. 2022;15:1627–1638. https://doi.org/10.2147/DMSO.S363762.
13. Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018;17(1):150. https://doi.org/10.1186/s12933-018-0787-8.
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853. Available at: https://pubmed.ncbi.nlm.nih.gov/9742976.
15. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. https://doi.org/10.1056/NEJMoa0806470.
16. Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes. 2006;114(7):384–388. https://doi.org/10.1055/s-2006-924152.
17. Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess. 2009;13(15):iii–50. https://doi.org/10.3310/hta13150.
18. Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care. 2006;29(8):1764–1770. https://doi.org/10.2337/dc06-0268.
19. Kolb H, Schneider B, Heinemann L, Lodwig V, Martin S. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care. 2007;30(1):183–184. https://doi.org/10.2337/dc06-1916.
20. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H et al. Selfmonitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49(2):271–278. https://doi.org/10.1007/s00125-005-0083-5.
21. Morgan CL, Griffin A, Chamberlain GH, Turkiendorf A, McEwan P, Evans LM et al. A longitudinal study into the new and long-term use of selfmonitoring blood glucose strips in the UK. Diabetes Ther. 2010;1(1):1–9. https://doi.org/10.1007/s13300-010-0001-9.
22. Kan K, Zhu W, Lu F, Shen Y, Gao F, Mo Y et al. Contribution of Structured Self-Monitoring of Blood Glucose to the Glycemic Control and the Quality of Life in Both Insulin- and Noninsulin-Treated Patients with Poorly Controlled Diabetes. Diabetes Technol Ther. 2017;19(12):707–714. https://doi.org/10.1089/dia.2017.0275.
23. Muhali SS, Muhali FS, Mfinanga SG, Sadiq AM, Marandu AA, Kyala NJ et al. Impact of Self-Monitoring Blood Glucose on Glycaemic Control Among Insulin-Treated Patients With Diabetes Mellitus in Northeastern Tanzania: A Randomised Controlled Trial. J Diabetes Res. 2024;2024:6789672. https://doi.org/10.1155/2024/6789672.
24. Al Hayek A, Al Dawish M. Evaluation of Patient Satisfaction and Clinical Efficacy of Using Blood Glucose Meters Featuring Color-Coded Indicators in Patients With Type 1 Diabetes: An Observational Hospital-Based Study. Cureus. 2022;14(4):e23764. https://doi.org/10.7759/cureus.23764.
25. AlRasheed AY, Hashim H, Alrofaie H. Adherence to Self-Monitoring of Blood Glucose and Its Related Factors Among Type 2 Diabetic Patients Attending Al-Ahsa Primary Health Care Centers in Saudi Arabia. Cureus. 2024;16(7):e65545. https://doi.org/10.7759/cureus.65545.
26. Rochmah N, Soetjipto S, Faizi M, Hisbiyah Y, Perwitasari RK, Fedora K et al. Frequent Self-Monitoring Blood Glucose Correlated to Better Medication Adherence and Glycemic Control in Children with Type 1 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2024;17:2203–2209. https://doi.org/10.2147/DMSO.S448508.
27. Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K et al. Selfmonitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe – recommendations from the international Central-Eastern European expert group. Diabetes Technol Ther. 2014;16(7):460–475. https://doi.org/10.1089/dia.2013.0302.
28. Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11(12):775–784. https://doi.org/10.1089/dia.2009.0091.
29. Xu Y, Tan DHY, Lee JY. Evaluating the impact of self-monitoring of blood glucose frequencies on glucose control in patients with type 2 diabetes who do not use insulin: A systematic review and meta-analysis. Int J Clin Pract. 2019;73(7):e13357. https://doi.org/10.1111/ijcp.13357.
30. Chircop J, Sheffield D, Kotera Y. Systematic Review of Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes. Nurs Res. 2021;70(6):487–497. https://doi.org/10.1097/NNR.0000000000000542.
31. Machry RV, Rados DV, Gregório GR, Rodrigues TC. Self-monitoring blood glucose improves glycemic control in type 2 diabetes without intensive treatment: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2018;142:173–187. https://doi.org/10.1016/j.diabres.2018.05.037.
32. Zou Y, Zhao S, Li G, Zhang C. The Efficacy and Frequency of Self-monitoring of Blood Glucose in Non-insulin-Treated T2D Patients: a Systematic Review and Meta-analysis. J Gen Intern Med. 2023;38(3):755–764. https://doi.org/10.1007/s11606-022-07864-z.
33. Grigor’eva IN, Notova TE. Apolypoprotein E gene polymorphism, gallstone disease, diabetes 2 type and lipid metabolism disorders. Ateroscleroz. 2023;19(1): 47–56. (In Russ.) https://doi.org/10.52727/2078-256X-2023-19-1-47-56.
34. Grigor’eva IN, Notova TE, Suvorova TS, Nepomnyashchikh DL. Polymorphisms of the ATP-binding cassette sterol efflux transporter genes g5 and g8 in cardiovascular diseases and type 2 diabetes mellitus. Ateroscleroz. 2024;20(1):6–15. (In Russ.) https://doi.org/10.52727/2078-256X-2024-20-1-6-15.
35. Farhan SA, Shaikh AT, Zia M, Kahara BR, Muneer R, Rehman M et al. Prevalence and Predictors of Home Use of Glucometers in Diabetic Patients. Cureus. 2017;9(6):e1330. https://doi.org/10.7759/cureus.1330.
36. Zgibor JC, Simmons D. Barriers to blood glucose monitoring in a multiethnic community. Diabetes Care. 2002;25(10):1772–1777. https://doi.org/10.2337/diacare.25.10.1772.
37. Polonsky WH, Fisher L. Self-monitoring of blood glucose in noninsulinusing type 2 diabetic patients: right answer, but wrong question: selfmonitoring of blood glucose can be clinically valuable for noninsulin users. Diabetes Care. 2013;36(1):179–182. https://doi.org/10.2337/dc12-0731.
38. Offringa R, Sheng T, Parks L, Clements M, Kerr D, Greenfield MS. Digital Diabetes Management Application Improves Glycemic Outcomes in People With Type 1 and Type 2 Diabetes. J Diabetes Sci Technol. 2018;12(3):701–708. https://doi.org/10.1177/1932296817747291.
39. Bailey TS, Wallace JF, Pardo S, Warchal-Windham ME, Harrison B, Morin R et al. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol. 2017;11(4):736–743. https://doi.org/10.1177/1932296816680829.
40. Freckmann G, Jendrike N, Baumstark A, Pleus S, Liebing C, Haug C. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors. Diabetes Ther. 2018;9(2):683–697. https://doi.org/10.1007/s13300-018-0392-6.
41. Pleus S, Jendrike N, Baumstark A, Mende J, Wehrstedt S, Haug C et al. Evaluation of System Accuracy, Precision, Hematocrit Influence, and User Performance of Two Blood Glucose Monitoring Systems Based on ISO 15197:2013/EN ISO 15197:2015. Diabetes Ther. 2024;15(2):447–459. https://doi.org/10.1007/s13300-023-01517-y.
42. Sheen YJ, Wang JM, Tsai PF, Lee WJ, Hsu YC, Wang CY et al. Accuracy of Pointof-Care Blood Glucometers in Neonates and Critically Ill Adults. Clin Ther. 2023;45(7):643–648. https://doi.org/10.1016/j.clinthera.2023.05.005.
43. Batrak GA, Batrak NV, Zhaburina MV. Type 2 diabetes mellitus: course and outcomes of pregnancy on the example of a clinical case. Meditsinskiy Sovet. 2024;(23):118–122. (In Russ.) https://doi.org/10.21518/ms2024-549.
44. Bolotskaya LL. Capabilities of mobile health to treat diabetes in the conditions of the COVID-19 pandemic. Meditsinskiy Sovet. 2020;(11):132–137. (In Russ.) https://doi.org/10.21518/2079-701X-2020-11-132-137.
45. Johari SM, Razalli NH, Chua KJ, Shahar S. The efficacy of self-monitoring of blood glucose (SMBG) intervention package through a subscription model among type-2 diabetes mellitus in Malaysia: a preliminary trial. Diabetol Metab Syndr. 2024;16(1):135. https://doi.org/10.1186/s13098-024-01379-9.
Review
For citations:
Grigor’eva IN, Tov NL. Digital technologies in self-monitoring of blood glucose and their clinical significance. Meditsinskiy sovet = Medical Council. 2025;(6):60-66. (In Russ.) https://doi.org/10.21518/ms2025-168
Views:
61
Email this article 